{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T11:46:12Z","timestamp":1776253572730,"version":"3.50.1"},"reference-count":45,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Diabetes mellitus is a common chronic disease that may lead to multimorbidity and high drug use. Therefore, this study aims to examine the prevalence of polypharmacy and hyperpolypharmacy among adult patients diagnosed with type 2 diabetes mellitus (T2DM) with its associated factors. Methods: This is a retrospective cross-sectional study conducted from 1 May 2023 to 31 October 2024. The outcomes in our study were polypharmacy (from five to nine drugs) and hyperpolypharmacy (\u226510 drugs). Baseline and demographic characteristics, along with multinomial logistic regression, were used to analyze the data. Results: The total number of patients with T2DM was 2435. The prevalence rate of polypharmacy was 46.98%, while hyperpolypharmacy was 24.27%. Older age was significantly associated with a higher risk of polypharmacy [OR = 1.031, 95% (1.022\u20131.040)] and hyperpolypharmacy [OR = 1.037, 95% (1.026\u20131.049)]. In addition, patients with higher levels of hemoglobin A1c showed a significantly higher risk of polypharmacy and hyperpolypharmacy ([OR = 1.162, 95% (1.105\u20131.221)] and [OR = 1.284, 95% (1.209\u20131.364)], respectively). The comorbidities that increased the odds of hyperpolypharmacy were hypertension [OR = 2.136, 95% (1.449\u20133.148)], pulmonary disease [OR = 2.375, 95% (1.292\u20134.367)], mental disorders [OR = 6.269; 95% (3.284\u201311.964], and congestive heart failure [OR = 8.014, 95% (2.768\u201323.200)]. Conclusions: The prevalence of polypharmacy and hyperpolypharmacy is high in patients with T2DM. The predictors that may play a significant role in increasing the risk of hyperpolypharmacy are the poor control of HbA1c and the coexistence of comorbidities. Providing proper prescribing of patients\u2019 therapy plans can improve individuals\u2019 health outcomes. Therefore, this study highlights the important role of primary care physicians in coordinating care, along with clinical pharmacists, in the identification of polypharmacy.<\/jats:p>","DOI":"10.3390\/jcm15083002","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T10:30:23Z","timestamp":1776249023000},"page":"3002","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Wise Prescriptions: Prevalence and Predictors of Polypharmacy in Patients with Type 2 Diabetes Mellitus in Primary Care: A Retrospective Cross-Sectional Study"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9578-9790","authenticated-orcid":false,"given":"Mohammed M.","family":"Alsultan","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam 34212, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danya R.","family":"Al Thani","sequence":"additional","affiliation":[{"name":"Family and Community Medicine Department, College of Medicine, King Fahd Hospital of the University, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara A.","family":"Shwaiheen","sequence":"additional","affiliation":[{"name":"Family and Community Medicine Department, College of Medicine, King Fahd Hospital of the University, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1360-7112","authenticated-orcid":false,"given":"Ethabah A.","family":"Al Drees","sequence":"additional","affiliation":[{"name":"Family and Community Medicine Department, College of Medicine, King Fahd Hospital of the University, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed A.","family":"Al Drees","sequence":"additional","affiliation":[{"name":"Family and Community Medicine Department, College of Medicine, King Fahd Hospital of the University, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reem D.","family":"AlQahtani","sequence":"additional","affiliation":[{"name":"Family and Community Medicine Department, College of Medicine, King Fahd Hospital of the University, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amnah A.","family":"Alnubi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam 34212, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuaa Y.","family":"Alali","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam 34212, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0674-5949","authenticated-orcid":false,"given":"Amani M.","family":"AlQarni","sequence":"additional","affiliation":[{"name":"Family and Community Medicine Department, College of Medicine, King Fahd Hospital of the University, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"ref_1","unstructured":"(2026, March 02). Diabetes Atlas. Global Diabetes Data Insights|IDF Diabetes Atlas. Diabetes Atlas. Available online: https:\/\/diabetesatlas.org\/data-by-location\/global\/."},{"key":"ref_2","unstructured":"(2026, March 02). Diabetes Atlas. Diabetes in the Middle East North Africa|IDF Diabetes Atlas. Diabetes Atlas. Available online: https:\/\/diabetesatlas.org\/data-by-location\/region\/middle-east-and-north-africa\/."},{"key":"ref_3","unstructured":"(2026, March 04). Diabetes Atlas. Saudi Arabia Diabetes Trends Insights|IDF Atlas. Diabetes Atlas. Available online: https:\/\/diabetesatlas.org\/data-by-location\/country\/saudi-arabia\/."},{"key":"ref_4","unstructured":"Sapra, A., and Bhandari, P. (2024). Diabetes. StatPearls, StatPearls Publishing."},{"key":"ref_5","unstructured":"Varghese, D., Ishida, C., Patel, P., and Koya, H.H. (2024). Polypharmacy. StatPearls, StatPearls Publishing."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"107804","DOI":"10.1016\/j.diabres.2019.107804","article-title":"The association between polypharmacy and adverse health consequences in elderly type 2 diabetes mellitus patients; a systematic review and meta-analysis","volume":"155","author":"Labib","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_7","unstructured":"World Health Organization (2004). A Glossary of Terms for Community Health Care and Services for Older Persons, WHO."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.therap.2019.10.001","article-title":"Polypharmacy: A general review of definitions, descriptions and determinants","volume":"75","author":"Guillot","year":"2020","journal-title":"Therapies"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Masnoon, N., Shakib, S., Kalisch-Ellett, L., and Caughey, G.E. (2017). What is polypharmacy? A systematic review of definitions. BMC Geriatr., 17.","DOI":"10.1186\/s12877-017-0621-2"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"101875","DOI":"10.1016\/j.jsps.2023.101875","article-title":"Prevalence of polypharmacy in heart failure patients: A retrospective cross-sectional study in a tertiary hospital in Saudi Arabia","volume":"31","author":"Alsultan","year":"2023","journal-title":"Saudi Pharm. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e020852","DOI":"10.1136\/bmjopen-2017-020852","article-title":"Polypharmacy among patients with diabetes: A cross-sectional retrospective study in a tertiary hospital in Saudi Arabia","volume":"8","author":"Alwhaibi","year":"2018","journal-title":"BMJ Open"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1111\/jgs.14718","article-title":"Is polypharmacy associated with frailty in older people? Results from the ESTHER cohort study","volume":"65","author":"Saum","year":"2017","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1192\/bjp.2022.160","article-title":"Association between polypharmacy and depression relapse in individuals with comorbid depression and type 2 diabetes: A UK electronic health record study","volume":"222","author":"Jeffery","year":"2023","journal-title":"Br. J. Psychiatry"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Tamene, F.B., Zeleke, T.K., Desalew, A.F., Tarekegn, G.Y., Sendekie, A.K., Tafere, S.M., Kiflu, M., Moges, T.A., Dagnew, F.N., and Wondm, S.A. (2025). Polypharmacy and associated factors among patients with type two diabetes mellitus with comorbidity: A multicenter cross-sectional study in Northwest Ethiopia. BMC Endocr. Disord., 25.","DOI":"10.1186\/s12902-025-02011-1"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e091997","DOI":"10.1136\/bmjopen-2024-091997","article-title":"Clinical factors associated with multimorbidity, polypharmacy and medication regimen complexity among adults with hypertension: A multicentre cross-sectional study","volume":"15","author":"Yazie","year":"2025","journal-title":"BMJ Open"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2147\/JMDH.S297423","article-title":"Polypharmacy and potential drug-drug interactions in home-dwelling older people\u2014A cross-sectional study","volume":"14","author":"Hermann","year":"2021","journal-title":"J. Multidiscip. Healthc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e00621","DOI":"10.1002\/prp2.621","article-title":"Polypharmacy, potentially serious clinically relevant drug-drug interactions, and inappropriate medicines in elderly people with type 2 diabetes and their impact on quality of life","volume":"8","author":"Torre","year":"2020","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1300\/J027v24n01_07","article-title":"Polypharmacy and possible drug-drug interactions among diabetic patients receiving home health care services","volume":"24","author":"Ibrahim","year":"2005","journal-title":"Home Health Care Serv. Q."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.21608\/scumj.2020.116531","article-title":"Prevalence of polypharmacy among Egyptian patients with type 2 diabetes mellitus","volume":"23","author":"Metwally","year":"2020","journal-title":"Suez Canal Univ. Med. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"48","DOI":"10.51847\/zimW7hb8OD","article-title":"Polypharmacy and medication compliance among patients with type 2 diabetes in Oman: A cross-sectional study","volume":"13","year":"2022","journal-title":"Arch. Pharm. Pract."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1111\/dom.15619","article-title":"Prescription medication use among patients with type 2 diabetes in the United States: 1999\u20132020","volume":"26","author":"Li","year":"2024","journal-title":"Diabetes Obes. Metab."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Li, J., Chattopadhyay, K., Xu, M., Chen, Y., Hu, F., Wang, X., and Li, L. (2019). Prevalence and predictors of polypharmacy prescription among type 2 diabetes patients at a tertiary care department in Ningbo, China: A retrospective database study. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0220047"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.2337\/dc24-0011","article-title":"Increasing medication use and polypharmacy in type 2 diabetes: The Danish experience from 2000 to 2020","volume":"47","author":"Johansson","year":"2024","journal-title":"Diabetes Care"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e14406","DOI":"10.1111\/dme.14406","article-title":"Characteristics associated with polypharmacy in people with type 2 diabetes: The Dutch Diabetes Pearl cohort","volume":"38","author":"Rutters","year":"2021","journal-title":"Diabet. Med."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Tang, H., Li, M., Ji, X., Zhao, Q., Wang, Y., Zhao, Y., Wang, Q., Xue, F., and Liu, X. (2025). Complication development trajectories for patients with type 2 diabetes mellitus: Evidence from a five-million retrospective cohort study. Front. Health Serv., 5.","DOI":"10.3389\/frhs.2025.1699513"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1573403X1604201229115531","article-title":"Complications of the type 2 diabetes mellitus","volume":"16","author":"Farmaki","year":"2020","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"S246","DOI":"10.2337\/dc26-S011","article-title":"11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes\u20142026","volume":"49","author":"Bajaj","year":"2026","journal-title":"Diabetes Care"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Khaira, M., Mathers, A., Benny Gerard, N., and Dolovich, L. (2020). The evolving role and impact of integrating pharmacists into primary care teams: Experience from Ontario, Canada. Pharmacy, 8.","DOI":"10.3390\/pharmacy8040234"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4103\/sjcp.sjcp_22_23","article-title":"The effectiveness of a medication therapy management (MTM) clinic for reducing HbA1c in patients with diabetes at a tertiary healthcare center in Saudi Arabia","volume":"2","author":"Almousa","year":"2023","journal-title":"Saudi J. Clin. Pharm."},{"key":"ref_31","first-page":"632","article-title":"Provision of medication therapy management by pharmacists to patients with type-2 diabetes mellitus in a federally qualified health center","volume":"42","author":"Ndefo","year":"2017","journal-title":"Pharm. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.13005\/bpj\/2282","article-title":"A Study of Polypharmacy in Patients with Co-Existing Diabetes Mellitus Type II and Hypertension in a Tertiary Care Center","volume":"14","author":"Khan","year":"2021","journal-title":"Biomed. Pharmacol. J."},{"key":"ref_33","first-page":"e02028","article-title":"Polypharmacy and its associated factors among patients with co-morbid hypertension and diabetes in a municipal hospital in Ghana","volume":"23","author":"Kwakye","year":"2024","journal-title":"Sci. Afr."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Zhong, W., Jiang, F., Wang, H., Yin, X., Zhang, B., Cui, H., and Zhou, J. (2026). Polypharmacy, determinants, and adverse outcomes in elderly patients with heart failure: A multicenter retrospective cohort study of 7,361 subjects. BMC Geriatr., 26.","DOI":"10.1186\/s12877-025-06948-9"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e34906","DOI":"10.1097\/MD.0000000000034906","article-title":"Heart failure and diabetes: Understanding the bidirectional relationship","volume":"102","author":"Elendu","year":"2023","journal-title":"Medicine"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Mutruc, V., Bologa, C., \u0218orodoc, V., Ceasovschih, A., Mor\u0103ra\u0219u, B.C., \u0218orodoc, L., Catar, O.E., and Lionte, C. (2025). Cardiovascular\u2013kidney\u2013metabolic syndrome: A new paradigm in clinical medicine or going back to basics?. J. Clin. Med., 14.","DOI":"10.3390\/jcm14082833"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"S239","DOI":"10.2337\/dc25-S011","article-title":"11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes\u20142025","volume":"48","author":"ElSayed","year":"2025","journal-title":"Diabetes Care"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"102472","DOI":"10.1016\/j.japh.2025.102472","article-title":"Medication prescribing checklists and their impact on patient safety: A scoping review","volume":"65","author":"Liu","year":"2025","journal-title":"J. Am. Pharm. Assoc."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/ejhpharm-2016-000967","article-title":"Deprescribing: A primary care perspective","volume":"24","author":"Duncan","year":"2017","journal-title":"Eur. J. Hosp. Pharm."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jad.2024.03.003","article-title":"Association between depression and diabetes mellitus and the impact of their comorbidity on mortality: Evidence from a nationally representative study","volume":"354","author":"Cai","year":"2024","journal-title":"J. Affect. Disord."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Ma, Y., Zhao, Y., Wei, R., Qiao, J., Luo, J., Zhang, L., Zhang, J., Deng, M., Yu, Y., and Wang, W. (2025). Economic costs and medications for diabetes in older patients in Beijing, China: Electronic insurance data analysis. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1549244"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Liu, X., Zhang, L., and Chen, W. (2023). Trends in economic burden of type 2 diabetes in China: Based on longitudinal claim data. Front. Public Health, 11.","DOI":"10.3389\/fpubh.2023.1062903"},{"key":"ref_44","unstructured":"Jandu, J.S., Mohanaselvan, A., Dahal, R., and Bista, S. (2024). Strategies to reduce polypharmacy in older adults. StatPearls, StatPearls Publishing."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.jsps.2020.11.002","article-title":"Impact of clinical pharmacist-led diabetes management clinic on health outcomes at an academic hospital in Riyadh, Saudi Arabia: A prospective cohort study","volume":"28","author":"Alsuwayni","year":"2020","journal-title":"Saudi Pharm. J."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/8\/3002\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T10:50:01Z","timestamp":1776250201000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/8\/3002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":45,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["jcm15083002"],"URL":"https:\/\/doi.org\/10.3390\/jcm15083002","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]}}}